FOREIGN COMMERCIALIZATION

A global sales network with predominant advantages in emerging markets

Products of Kexing Biopharm sold in 100%of emerging markets with a population of more than 100 million

Products of Kexing Biopharm sold in 100%of the top 30 emerging markets in terms of GDP

Exploring European Market in 2021

20+years of experience in internationalization
20+  years of experience in overseas commercialization

40+countries and regions
Stepping into major ROW countries and markets through FDF and API and other products

50+salespersons
Overseas Marketing Division in charge of regulatory market access, promotion, marketing, ommerce,overseas subsidiaries, etc.